Relapsed or Refractory
specific13
Centers
0
Active Trials
$27M
Cancer Funding
Top Centers for Relapsed or Refractory(13)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive High-Volume Research Center | 70.0 |
| 2 | Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive Active Research Program | 67.3 |
| 3 | Abramson Cancer Center of the University of PennsylvaniaPhiladelphia, PA NCI Comprehensive Active Research Program | 64.6 |
| 4 | NCI Clinical Active Research Program | 61.9 |
| 5 | NCI Comprehensive Active Research Program | 59.2 |
| 6 | NCI Comprehensive Active Research Program | 56.5 |
| 7 | Moffitt Cancer CenterTampa, FL NCI Comprehensive Active Research Program | 53.8 |
| 8 | Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive Active Research Program | 51.2 |
| 9 | Siteman Cancer CenterSt. Louis, MO NCI Comprehensive Active Research Program | 48.5 |
| 10 | VCU Massey Comprehensive Cancer CenterRichmond, VA NCI Comprehensive Active Research Program | 45.8 |
| 11 | Huntsman Cancer Institute at the University of UtahSalt Lake City, UT NCI Comprehensive Active Research Program | 43.1 |
| 12 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 40.4 |
| 13 | Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical | 37.7 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →